SCN5A and heart failure: Previously it has been used to demonstrate changes in INa during heart failure (Berecki et al., 2010), changes in intracellular Ca2+ concentration (Casini et al., 2009), and in the setting of SCN5A mutations (Remme et al., 2006; Lieve et al., 2017).